Comparison of three methods for identifying medical drug-psychotropic drug interactions

被引:4
|
作者
Strain, JJ [1 ]
Chiu, NM
Brodsky, M
Karim, A
Caliendo, G
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan
[3] Mt Sinai NYU Med Ctr Hlth Syst, Dept Neurol, Mt Sinai Sch Med, New York, NY 10029 USA
[4] Mt Sinai Hosp, Dept Pharm, New York, NY 10029 USA
关键词
D O I
10.1016/S0163-8343(02)00196-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Three methods for examining drug-drug interactions were compared to understand advantages and disadvantages of each: ePocrates; Interact; The Mount Sinai multiple source for the evaluation of drug-drug interactions (MS). ePocrates is a commonly employed software system utilized in a hand held computer, the PalmPilot. Interact is on a CD-ROM, and promoted by the American Psychiatric Association Press. The MS system was developed by the authors and utilizes six separate references sources to ascertain the presence and significance of drug-drug interactions. Commonly prescribed neurology and psychotropic medication interactions were compared using the three systems. ePocrates did not list the significance level of the interaction, e.g., (major, moderate, minor), often did not include a mechanism of action, and several commonly employed medications were not included. It did permit examining several drugs at the same time, and was easily carried on the person of the physician. Interact often contained old references, several drugs were not included, was not adapted to a hand held computer format, and had no update since 1999. The MS system listed level of significance, provided mechanism of action, and advice to the practitioner including recommendations. It is not portable, requiring a laptop or desk top computer or hard copy, and only searches one drug at a time. It is hoped that the advantages of each of these three systems may be incorporated into systems of the future. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [31] Identifying drug–genotype interactions
    Charlotte Harrison
    Nature Reviews Drug Discovery, 2009, 8 : 109 - 109
  • [32] Avoiding psychotropic drug interactions in the cardiovascular patient
    DeVane, CL
    Markowitz, JS
    BULLETIN OF THE MENNINGER CLINIC, 2000, 64 (01) : 49 - 59
  • [33] DRUG INTERACTIONS INVOLVING PSYCHOTROPIC-DRUGS
    SHADER, RI
    CIRAULO, DA
    GREENBLATT, DJ
    PSYCHOSOMATICS, 1978, 19 (11) : 671 - +
  • [34] Metabolic drug interactions with new psychotropic agents
    Spina, E
    Scordo, MG
    D'Arrigo, C
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (05) : 517 - 538
  • [35] GUIDE TO DRUG-INTERACTIONS WITH PSYCHOTROPIC AGENTS
    MARCO, LA
    RANDELS, PM
    SEXAUER, JD
    DRUG THERAPY, 1979, 9 (04) : 45 - 56
  • [36] Pharmacokinetic drug interactions of new psychotropic agents
    Spina, E
    EUROPEAN PSYCHIATRY, 2002, 17 : 14S - 14S
  • [37] Comparison between three information sources of drug interactions
    López Vázquez, P.
    Rodríguez Moreno, C.
    Velasco González, M.
    Tocoian, A. V.
    Figueiras Guzmán, A.
    Tato Herrero, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 45 - 45
  • [38] Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions: Comparison of Data Mining of Spontaneous Reporting Databases
    Skvrce, N. Mirosevic
    Sarinic, V. Macolic
    Krnic, D.
    Tomic, S.
    Mucalo, I.
    Bozina, N.
    DRUG SAFETY, 2011, 34 (10) : 910 - 910
  • [39] OUR SCREENING METHODS OF PSYCHOTROPIC DRUG ASSESSMENT
    PODVALOV.I
    VOTAVA, Z
    ACTIVITAS NERVOSA SUPERIOR, 1966, 8 (04): : 434 - &
  • [40] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    Brett A. English
    Marcus Dortch
    Larry Ereshefsky
    Stanford Jhee
    Current Psychiatry Reports, 2012, 14 : 376 - 390